For the Inventor, By the Inventor

Enter assignee name

San Diego, CA, United States of America

Vical Incorporated

USPTO Granted Patents = 64

EPO Patents = 9

Trademarks = 2

Forward Citations = 5,402

Loading Chart...

Loading Chart...

49 inventors (with patents filed for the assignee):

Adrian Vilalta (18 out of 18 patents)

Michal Margalith (14 out of 14 patents)

Lichun Dong (13 out of 13 patents)

4. David Martin Koelle (13 out of 33 patents)

5. Andrew John Geall (12 out of 99 patents)

6. Philip L Felgner (11 out of 49 patents)

7. Carl J Wheeler (10 out of 10 patents)

8. Mary Kopke Wloch (9 out of 9 patents)

9. Jon Asher Wolff (7 out of 97 patents)

10. Dennis A Carson (6 out of 87 patents)

11. Gary H Rhodes (6 out of 9 patents)

12. Robert Wallace Malone (6 out of 16 patents)

13. Gary G Hermanson (5 out of 7 patents)

14. Catherine J Luke (5 out of 7 patents)

15. Thomas G Evans (5 out of 5 patents)

Core Competencies:

Polynucleotide-Based Vaccines

HSV-2 Vaccination

Human Cytomegalovirus

Influenza Virus Vaccine

Adjuvant Compositions

Cancer Treatment Methods

Lipid-Mediated Administration

Gene Therapy Plasmids

Cationic Lipids

Immune Response Enhancement

Interferon-Expressing Polynucleotides

Cytofectin Dimer Technology

64 patents: Sort by Forward Citations

1. 9205146 - Compositions and methods for vaccinating against HSV-2 (2015-12-08),

2. 9180162 - Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection (2015-11-10),

3. 9161973 - Compositions and methods for vaccinating against HSV-2 (2015-10-20),

4. 9102950 - Compositions and methods for enhancing immune responses to vaccines (2015-08-11),

5. 8999345 - Compositions and methods for enhancing immune responses to vaccines (2015-04-07),

6. 8852611 - Compositions and methods for vaccinating against HSV-2 (2014-10-07),

7. 8852610 - Compositions and methods for vaccinating against HSV-2 (2014-10-07),

8. 8840904 - Compositions and methods for vaccinating against HSV-2 (2014-09-23),

9. 8840903 - Compositions and methods for vaccinating against HSV-2 (2014-09-23),

10. 8834894 - Compositions and methods for vaccinating against HSV-2 (2014-09-16),

11. 8828408 - Compositions and methods for vaccinating against HSV-2 (2014-09-09),

12. 8821890 - Influenza virus vaccine composition and methods of use (2014-09-02),

13. 8673317 - [object Object] (2014-03-18),

14. 8541628 - Complex cationic lipids having quaternary nitrogens therein (2013-09-24),

15. 8435557 - Method for producing sterile polynucleotide based medicaments (2013-05-07),

Vical Incorporated is a biopharmaceutical company based in California, USA. With a focus on the development of innovative vaccines and therapeutic products for the prevention and treatment of diseases, Vical is dedicated to improving the lives of patients worldwide. Their expertise lies in the areas of infectious diseases, cancer immunotherapy, and rare genetic diseases. Vical's commitment to advancing the field of biopharmaceuticals drives them to continuously explore new technologies and collaborate with partners. Through cutting-edge research and development, Vical strives to deliver safe and effective solutions to challenging medical conditions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

64 Patents

#97 in San Diego, CA

#1,285 in California

#5,446 in US

#11,029 in the World

San Diego, CA, United States of America

Vical Incorporated

Forward Citations = 5,402

49 inventors:

Adrian Vilalta (18 out of 18 patents)

Michal Margalith (14 out of 14 patents)

Lichun Dong (13 out of 13 patents)

4. David Martin Koelle (13 out of 33 patents)

5. Andrew John Geall (12 out of 99 patents)

Please report any incorrect information to support@idiyas.com

Loading…